1. The Guardian Connect system uses predictive analytics and artificial intelligence technology from IBM Watson Health to analyze glucose levels.
2. Adcetris is the first new frontline treatment for advanced Hodgkin lymphoma in 40 years.
3. Lucentis is available as a 0.3 milligram prefilled syringe to treat diabetic macular edema and diabetic retinopathy.
4. Hizentra is the first subcutaneous immunoglobulin approved to treat chronic inflammatory demyelinating polyneuropathy, a rare autoimmune disorder that affects the peripheral nerves.
More articles on supply chain:
US grants Amazon patent for drones that react to human gestures
California issues cease-and-desist order to subsidiary of AmerisourceBergen: 6 things to know
FDA approves first frontline treatment for advanced Hodgkin lymphoma in 40 years
